Abacus FCF Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,942
| Closed | -$2.01M | – | 164 |
|
|
2023
Q4 | $2.01M | Buy |
4,942
+2,178
| +79% | +$886K | 0.58% | 54 |
|
|
2023
Q3 | $961K | Buy |
+2,764
| New | +$961K | 0.51% | 70 |
|
|
2022
Q2 | – | Sell |
-3,228
| Closed | -$842K | – | 185 |
|
|
2022
Q1 | $842K | Buy |
+3,228
| New | +$842K | 0.28% | 143 |
|
|
2021
Q3 | – | Sell |
-4,605
| Closed | -$894K | – | 151 |
|
|
2021
Q2 | $894K | Sell |
4,605
-341
| -7% | -$66.2K | 0.46% | 110 |
|
|
2021
Q1 | $1.06M | Sell |
4,946
-31
| -0.6% | -$6.65K | 0.54% | 79 |
|
|
2020
Q4 | $1.17M | Sell |
4,977
-465
| -9% | -$109K | 0.68% | 80 |
|
|
2020
Q3 | $1.47M | Buy |
5,442
+1,953
| +56% | +$527K | 0.79% | 82 |
|
|
2020
Q2 | $1.02M | Buy |
+3,489
| New | +$1.02M | 0.96% | 67 |
|